<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.fiercepharma.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Zimmer</title>
 <link>http://www.fiercepharma.com/tags/zimmer</link>
 <description></description>
 <language>en</language>
<item>
 <title>Zimmer device prompts database push</title>
 <link>http://www.fiercepharma.com/story/zimmer-device-prompts-database-push/2008-07-29?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>&lt;p&gt;Last week, Zimmer suspended sales of a hip-replacement device after doctors complained that some patients found the joint socket extremely painful. This week, experts are calling for a national artificial joint database to catch such problems earlier. &lt;a href=&quot;http://www.nytimes.com/2008/07/29/business/29hip.html?_r=1&amp;amp;hp&amp;amp;oref=slogin&quot;&gt;Report&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.fiercepharma.com/story/zimmer-device-prompts-database-push/2008-07-29#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/medical-device">medical device</category>
 <category domain="http://www.fiercepharma.com/tags/zimmer">Zimmer</category>
 <pubDate>Tue, 29 Jul 2008 10:51:45 -0400</pubDate>
 <dc:creator>Tracy Staton</dc:creator>
 <guid isPermaLink="false">9414 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>Zimmer mulls $250M in doc-contract buyouts</title>
 <link>http://www.fiercepharma.com/story/zimmer-mulls-250m-doc-contract-buyouts/2008-05-19?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>&lt;p&gt;You&#039;ve heard of sports teams buying out their coaches&#039; contracts. Well, now there&#039;s a device maker considering buying out its deals with surgeons. In a move designed to clear up legal troubles over its contracts with doctors, Zimmer is considering cutting off royalty contracts with many of them. To get out of those long-term deals, the company would give those docs up-front payments. Though Zimmer won&#039;t say how much that&#039;s likely to cost, analysts estimate the buyouts might run to $250 million.&lt;/p&gt;
&lt;p&gt;And that would come on top of a $169.5 million fine levied by the U.S. government last year, plus the $54 million Zimmer expects to spend on new compliance measures, such as disclosing doc payments in an online database.&lt;/p&gt;
&lt;p&gt;- read the &lt;a href=&quot;http://www.ft.com/cms/s/0/b38b6202-2373-11dd-b214-000077b07658.html&quot;&gt;story&lt;/a&gt; in the &lt;em&gt;Financial Times&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Related Article:&lt;br /&gt;&lt;/strong&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/also-noted-bayer-sues-watson-over-yasmin-zimmer-weeds-out-doc-conflicts/2008-04-21&quot;&gt;Zimmer weeds out doc conflicts&lt;/a&gt;&lt;/p&gt;</description>
 <comments>http://www.fiercepharma.com/story/zimmer-mulls-250m-doc-contract-buyouts/2008-05-19#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/buyouts">buyouts</category>
 <category domain="http://www.fiercepharma.com/tags/medical-device">medical device</category>
 <category domain="http://www.fiercepharma.com/tags/medical-device-news">medical device news</category>
 <category domain="http://www.fiercepharma.com/tags/zimmer">Zimmer</category>
 <pubDate>Mon, 19 May 2008 11:15:48 -0400</pubDate>
 <dc:creator>Tracy Staton</dc:creator>
 <guid isPermaLink="false">9043 at http://www.fiercepharma.com</guid>
</item>
</channel>
</rss>
